Endometriosis market calls for better treatment methods with increased safety profilesPress release August 4, 2014 Endometriosis market, industry reports
Endometriosis is a common female health condition where the endometrial tissue, which is usually found inside the lining of the uterus, appear and grows outside the uterine cavity.
The World Endometriosis Research Foundation, a charity that supports research projects in endometriosis, estimates that around 170 million women have the painful condition globally. The market for the treatment of endometriosis, which is one of the major causes of infertility, is weak mainly because of the lack of disease awareness and diagnostic techniques, poor safety and efficacy profiles. Currently, the market comprises only of off-label and generic drugs that can be segmented under four major therapeutic categories: gonadotropin-releasing hormone agonists, non-steroidal anti-inflammatory drugs (NSAIDs), progestin and contraceptive pills. The drugs only provide relief to the symptoms without providing an absolute cure, showing the extent to which the market could grow. There is demand for better drugs with improved safety profiles, which would further increase in the future, especially because of the increasing incident rates of endometriosis as people become more aware of the disease.
This report, Global Endometriosis Market 2014-2018, forecasts that the market will grow at a CAGR of 2.86% in the period from 2013 to 2018. It also presents the market scenario and considers the revenue generated from the sales of various drugs used in treatment of endometriosis.
The future of the endometriosis market looks promising with increasing efforts being made in research on surgical as well as pharmaceutical treatments. Even non-invasive diagnostics like next-generation MRIs are expected to become some of the major tools for diagnosis of the condition. However, laparoscopy still remains the method most preferred by healthcare institutions. Headways are also being made towards genetic and bio-molecular diagnostic tests.
Endometriosis affects about 10% of women in Asian countries, which is higher than elsewhere. A majority of the people still rely on traditional treatment methods, including acupuncture and herbal therapies.
Despite this, it the US that remains the largest market for endometriosis globally, and Europe comes close. The emerging economies of Asia Pacific, Latin America and Middle East are also forecasted to exhibit growth in the coming years and record a CAGR of 6.4% during the same time.
Inspite of the opportunities present, the endometriosis market faces challenges. Expiring patents of endometriosis drugs lead to loss of exclusive rights of branded products. This followed by the introduction of low-priced generics acts as deterrents, especially to the key players who are investing huge amounts for the research of this disease.
For further insights,
Visit: Endometriosis market calls for better treatment methods with increased safety profiles
About Research on Global Markets
Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.
For more details on the content of each report and ordering information please contact:
Email: [email protected]
US: +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
Endometriosis market, industry reports